Cite
HARVARD Citation
D'Angelo, S. et al. (2020). Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial. Journal for immunotherapy of cancer. 8 (1), p. . [Online].